Topic
Treatments and devices already helping people, or shown in a human trial, with the limits stated plainly. 14 verified stories. Stories come from Silver Spring, Denver, and Westbrook. Each one is checked and linked to the original report.
KidsVolunteersStudentsKindnessNeighborsWildlife conservationAnimal rescueSchoolsFirst respondersInclusionParksDogs
Health & TechJemperli, or dostarlimab, received accelerated approval for untreated stage II or III dMMR or MSI-H rectal cancer. In a 154-patient trial, nearly three-fourths needed no chemo, radiation, or surgery after more than two years. That subtype is about 3 percent of rectal cancers.
Verified · U.S. Food and Drug Administration
Health & TechIn a study of 72 children ages 6 to 11, 10 weeks of occupational therapy with horses lowered cortisol more than the same therapy in a clinic. It is not a cure.
Verified · Colorado State University
Health & TechNew England Cancer Specialists expects its first CAR T infusion in November, so fewer Mainers have to travel to Boston. One Dresden patient treated in Boston says doctors cannot find detectable cancer cells. That is her case, not a guarantee.
Verified · Portland Press Herald
Health & TechThe FDA expanded Anktiva, given with BCG, to adults with BCG-unresponsive high-grade papillary-only bladder cancer. A related trial, not this exact group, saw a 62 percent complete response.
Verified · U.S. Food and Drug Administration
Health & TechIn an 80-week trial of 1,152 adults with obesity and type 2 diabetes, the highest dose of the experimental drug retatrutide cut weight more than placebo and lowered HbA1c. It is not FDA-approved.
Verified · Medical Xpress
Health & TechIn a small NIH-funded hospital study, 13 patients used a phone app to question their EEG monitor. False seizure alarms fell by about 80 percent. Larger outpatient trials are planned.
Verified · National Institutes of Health (NIH)
Health & TechZanvastro (zilganersen) is approved for a rare, often fatal brain disorder. In a controlled trial, treated patients 5 and older with walking trouble were faster at 61 weeks, and treated 2- to 4-year-olds gained motor skills while untreated children declined. It is not a cure.
Verified · Nature Biotechnology
Health & TechOn October 9 the FDA approved Teva's Weltruza, a long-acting injection for adults with schizophrenia. Teva expects a U.S. launch within weeks. It is not a cure.
Verified · CNBC
Health & TechHovilpri (pritelivir) is for immunocompromised adults whose lesions did not respond to acyclovir, valacyclovir, or famciclovir. The trial was open-label, and herpes still has no cure.
Verified · U.S. Food and Drug Administration
Health & TechIn a 712-patient trial, adding atezolizumab to chemotherapy after surgery halved the risk of the cancer returning or of death. Median disease-free survival was not reached, and overall survival was not the result reported.
Verified · U.S. Food and Drug Administration
Health & TechTen people with advanced retinitis pigmentosa received an experimental optogenetic injection plus special goggles. Some sensed light better. Normal vision did not return.
Verified · University of Pittsburgh
Health & TechIn a 654-person maintenance trial, median progression-free survival was 24.9 months with tucatinib and 16.3 months with placebo. Overall survival is not known yet.
Verified · U.S. Food and Drug Administration
Health & TechIn a 282-person trial, the cancer took longer to worsen than with a common chemoimmunotherapy. Survival is not proven, and the approval excludes a 17p deletion.
Verified · U.S. Food and Drug Administration
Health & TechIn a study of 62 children, the Autus valve met the FDA's six-month bar. Only two have been expanded so far, and longer follow-up is still underway.
Verified · U.S. Food and Drug Administration